Abbott Laboratories (NYSE:ABT) is a leader in the healthcare sector with a vast portfolio of products across medical devices, nutrition, and diagnostics tools. The company is also recognized as a dividend aristocrat with an impressive 46 consecutive years of annually increasing their dividend with a history that has been defined by steady earnings growth and effective management. The stock is up 100% on a total return basis over the past three years with a good reception in the market from new innovations and recent acquisitions.
ABT just announced its Q3 earnings release which